BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sohn SH, Kim B, Sul HJ, Choi BY, Kim HS, Zang DY. Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling. Onco Targets Ther 2020;13:1027-35. [PMID: 32099405 DOI: 10.2147/OTT.S226951] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu D, Liu X, Mu J, Yang J, Wu F, Zhou H. Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers. Biomolecules 2022;12:392. [DOI: 10.3390/biom12030392] [Reference Citation Analysis]
2 Gao X, Lu C, Chen C, Sun K, Liang Q, Shuai J, Wang X, Xu Y. ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer. Onco Targets Ther 2020;13:6629-43. [PMID: 32753897 DOI: 10.2147/OTT.S253841] [Reference Citation Analysis]
3 Wang C, Chu M. Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis. Front Oncol 2021;11:783309. [PMID: 35087755 DOI: 10.3389/fonc.2021.783309] [Reference Citation Analysis]
4 Zhang Y, Ma H, Chen C. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis. Oncol Rep 2021;46:134. [PMID: 34036383 DOI: 10.3892/or.2021.8085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fu Y, Peng Y, Zhao S, Mou J, Zeng L, Jiang X, Yang C, Huang C, Li Y, Lu Y, Wu M, Yang Y, Kong T, Lai Q, Wu Y, Yao Y, Wang Y, Gou L, Yang J. Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma. Front Cell Dev Biol 2021;9:689727. [PMID: 34307367 DOI: 10.3389/fcell.2021.689727] [Reference Citation Analysis]
6 El Darsa H, El Sayed R, Abdel-Rahman O. MET Inhibitors for the Treatment of Gastric Cancer: What's Their Potential? J Exp Pharmacol 2020;12:349-61. [PMID: 33116950 DOI: 10.2147/JEP.S242958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
7 Dembic Z. Antitumor Drugs and Their Targets. Molecules 2020;25:E5776. [PMID: 33297561 DOI: 10.3390/molecules25235776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Qi Z, Wang J, Li Y, Xu Y, Wang F. MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/5819295] [Reference Citation Analysis]
9 Sohn SH, Sul HJ, Kim B, Kim HS, Kim BJ, Lim H, Kang HS, Soh JS, Kim KC, Cho JW, Seo J, Koh Y, Zang DY. RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer. J Cancer 2021;12:4616-25. [PMID: 34149925 DOI: 10.7150/jca.56014] [Reference Citation Analysis]